本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ionis Pharmaceuticals, Inc

45.97
+1.132.52%
成交量:48.88萬
成交額:2,262.66萬
市值:76.39億
市盈率:-13.21
高:47.42
開:46.68
低:45.76
收:44.84
52周最高:86.74
52周最低:44.66
股本:1.66億
流通股本:1.62億
量比:1.02
換手率:0.30%
股息:- -
股息率:- -
每股收益(TTM):-3.4800
每股收益(LYR):-2.3812
淨資產收益率:-105.50%
總資產收益率:-12.42%
市淨率:17.37
市盈率(LYR):-19.30

資料載入中...

2025/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/20

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities